New Parkinson’s Treatments in the Clinical Trial Pipeline for ...
2023年9月26日 — Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
FDA Approves New Treatment for Advanced Parkinson’s Disease
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help...
New Treatments for Parkinson’s Disease | APDA
2021年10月19日 — Exploring seven recently approved Parkinson’s treatments. Update: View our updated post of new Parkinson’s treatments in the clinical trial pipeline for 2023 and 2024. Remarkably, in the last five years, seven new medications have been approved for the treatment of the motor symptoms of Parkinson’s disease (PD), with two approved in 2020 ...
New Parkinson’s drug could slow or reverse progression of ...
2024年8月21日 — “People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is a long way to go for development of this treatment,” Michael S. Okun, M.D., Parkinson’s Foundation medical adviser and director at the Norman Fixel Institute for ...
U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for ...
2024年10月17日 — VYALEV™ is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's disease; Adults treated with VYALEV reported superior improvement in "on" time without troublesome dyskinesia, compared to oral immediate-release carbidopa/levodopa 1
FDA Reviewing Four New Parkinson's Medications in 2024
2024年7月18日 — Four new medications to treat Parkinson’s disease symptoms engaged with the review process by the U.S. Food and Drug Administration in 2024. Learn more.
FDA approves new Parkinson’s treatment based on clinical ...
2024年8月8日 — The U.S. Food and Drug Administration (FDA) approved on Aug. 7 a new medication that lasts longer and requires fewer doses for treating Parkinson’s Disease, potentially offering patients significant relief from the disease’s debilitating symptoms.
Novel cell therapy continues to show promise for Parkinson's ...
2024年3月6日 — — New clinical trial data for bemdaneprocel, a promising stem cell-derived therapy for Parkinson’s disease, continues to show positive results 18 months after treatment, scientists reported today at an international conference in Portugal.
Breakthrough Parkinson’s Treatment Enters Human Trials After ...
2024年8月7日 — A clinical trial has begun to offer a new treatment to people with Parkinson’s disease, following a study by University of Wisconsin–Madison scientists. This study, conducted on non-human primates, confirmed that the therapeutic delivery method is safe and feasible.
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
2024年3月11日 — Produced by the US biotechnology company Vaxxinity, the immunotherapy candidate codenamed UB-312 is the first treatment shown to be capable of reducing concentrations of alpha-synuclein (α-syn) in cerebrospinal fluid, marking a significant step forward in slowing – or even halting – the disorder's progress.